Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  TGFbDNRII-transduced autologous tumor-infiltrating lymphocytes
Find trials that include:  Any drugs shown
Results 1-2 of 2 for your search:
Start Over
Gene-Modified T cells in Treating Patients with Locally Advanced or Stage IV Solid Tumors Expressing NY-ES0-1
Status: Not yet active
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: I 258514, NCI-2015-02080, NCT02650986
Genetically Modified T-Cells Followed by Aldesleukin in Treating Patients with Stage III-IV Melanoma
Status: Active
Phase: No phase specified
Type: Treatment
Age: 7 and over
Trial IDs: 2012-0758, NCI-2014-01211, RP110553-P4, RM1012-012-1, NCT01955460
Start Over